Inovio Pharmaceuticals, Inc.
CANCER VACCINES TARGETING MESOTHELIN AND USES THEREOF

Last updated:

Abstract:

Disclosed herein are nucleic acid molecules comprising one or more nucleic acid sequences that encode a modified consensus mesothelin antigen. Vectors, compositions, and vaccines comprising one or more nucleic acid sequences that encode a modified consensus mesothelin antigen are disclosed. Methods of treating a subject with a mesothelin-expressing tumor and methods of preventing a mesothelin-expressing tumor are disclosed. Modified consensus mesothelin antigen is disclosed.

Status:
Application
Type:

Utility

Filling date:

7 Sep 2021

Issue date:

30 Dec 2021